Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Montelukast now available in Spain

June 23, 1998

Dompe's novel antihistamine in phase I testing

June 18, 1998

ABT-761: relationship between effect on exercise-induced bronchoconstriction and 5-LO inhibition

June 18, 1998

ADIR describes new PDE IV-inhibitory flavones

June 17, 1998

Biogen seeks partners to continue development of gelsolin

June 16, 1998

New antiallergic and antiinflammatory compounds developed by Astra researchers

June 11, 1998

tgAAV-CFTR research results published in The Lancet

June 11, 1998

Pfizer discloses indazole inhibitors of PDE and TNF production

June 11, 1998

Byk Gulden patents another series of thiazole PDE IV inhibitors

June 9, 1998

Genome Therapeutics reaches milestone in Schering-Plough alliance

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...